Skip to main content
. 2005 Jun;2(3):64.

graphic file with name BH0203064_f1.jpg

Approval projections for therapeutic mAbs

Includes sales potential in 2008 (in billions)

SOURCES: PROTEIN THERAPEUTIC SUCCESS RATES INCREASE WITH BIOTECH ADVANCES, TUFTS CENTER FOR THE STUDY OF DRUG DEVELOPMENT, BOSTON, MARCH 2005, AND MONOCLONAL ANTIBODY THERAPIES: EVOLVING INTO A $30 BILLION MARKET, DATAMONITOR, LONDON, APRIL 2005